Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

Trial Identifier: D8850C00019
Sponsor: AstraZeneca
Start Date: January 2023
Primary Completion Date: January 2025
Study Completion Date: January 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Chiba, Japan
Japan Fukushima, Japan
Japan Hiroshima, Japan
Japan Hokkaido, Japan
Japan Hyogo, Japan
Japan Ibaraki, Japan
Japan Ishikawa, Japan
Japan Iwate, Japan
Japan Kanagawa, Japan
Japan Kyoto, Japan
Japan Mie, Japan
Japan Tottori, Japan